MODIV INDUSTRIAL INC (MDV) Stock Fundamental Analysis

NYSE:MDV • US60784B1017

15.28 USD
-0.06 (-0.39%)
Last: Feb 25, 2026, 02:27 PM
Fundamental Rating

4

Taking everything into account, MDV scores 4 out of 10 in our fundamental rating. MDV was compared to 122 industry peers in the Diversified REITs industry. MDV has only an average score on both its financial health and profitability. While showing a medium growth rate, MDV is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year MDV was profitable.
  • MDV had a positive operating cash flow in the past year.
  • In the past 5 years MDV reported 4 times negative net income.
  • MDV had a positive operating cash flow in each of the past 5 years.
MDV Yearly Net Income VS EBIT VS OCF VS FCFMDV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -0.54%, MDV is doing worse than 64.75% of the companies in the same industry.
  • MDV has a worse Return On Equity (-1.63%) than 64.75% of its industry peers.
  • MDV has a better Return On Invested Capital (3.21%) than 61.48% of its industry peers.
  • MDV had an Average Return On Invested Capital over the past 3 years of 2.12%. This is in line with the industry average of 3.08%.
  • The last Return On Invested Capital (3.21%) for MDV is above the 3 year average (2.12%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.54%
ROE -1.63%
ROIC 3.21%
ROA(3y)-1.01%
ROA(5y)-3.09%
ROE(3y)-3.42%
ROE(5y)-9.27%
ROIC(3y)2.12%
ROIC(5y)1.53%
MDV Yearly ROA, ROE, ROICMDV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

  • With an excellent Operating Margin value of 42.50%, MDV belongs to the best of the industry, outperforming 88.52% of the companies in the same industry.
  • MDV's Operating Margin has improved in the last couple of years.
  • MDV has a better Gross Margin (92.56%) than 94.26% of its industry peers.
  • In the last couple of years the Gross Margin of MDV has grown nicely.
Industry RankSector Rank
OM 42.5%
PM (TTM) N/A
GM 92.56%
OM growth 3Y67.86%
OM growth 5Y18.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.08%
GM growth 5Y2.86%
MDV Yearly Profit, Operating, Gross MarginsMDV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MDV is destroying value.
  • MDV has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, MDV has more shares outstanding
  • Compared to 1 year ago, MDV has a worse debt to assets ratio.
MDV Yearly Shares OutstandingMDV Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
MDV Yearly Total Debt VS Total AssetsMDV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

  • Based on the Altman-Z score of 0.11, we must say that MDV is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.11, MDV is doing worse than 72.95% of the companies in the same industry.
  • MDV has a debt to FCF ratio of 17.98. This is a negative value and a sign of low solvency as MDV would need 17.98 years to pay back of all of its debts.
  • MDV's Debt to FCF ratio of 17.98 is amongst the best of the industry. MDV outperforms 80.33% of its industry peers.
  • A Debt/Equity ratio of 1.70 is on the high side and indicates that MDV has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 1.70, MDV is doing worse than 65.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.7
Debt/FCF 17.98
Altman-Z 0.11
ROIC/WACC0.5
WACC6.37%
MDV Yearly LT Debt VS Equity VS FCFMDV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

  • MDV has a Current Ratio of 4.25. This indicates that MDV is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of MDV (4.25) is better than 94.26% of its industry peers.
  • MDV has a Quick Ratio of 4.25. This indicates that MDV is financially healthy and has no problem in meeting its short term obligations.
  • MDV has a Quick ratio of 4.25. This is amongst the best in the industry. MDV outperforms 94.26% of its industry peers.
Industry RankSector Rank
Current Ratio 4.25
Quick Ratio 4.25
MDV Yearly Current Assets VS Current LiabilitesMDV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

4

3. Growth

3.1 Past

  • MDV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 157.14%, which is quite impressive.
  • The Revenue has decreased by -0.59% in the past year.
  • MDV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.76% yearly.
EPS 1Y (TTM)157.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)-0.59%
Revenue growth 3Y7.26%
Revenue growth 5Y13.76%
Sales Q2Q%0.27%

3.2 Future

  • Based on estimates for the next years, MDV will show a very strong growth in Earnings Per Share. The EPS will grow by 22.95% on average per year.
  • Based on estimates for the next years, MDV will show a small growth in Revenue. The Revenue will grow by 1.05% on average per year.
EPS Next Y-174.07%
EPS Next 2Y-25.69%
EPS Next 3Y22.95%
EPS Next 5YN/A
Revenue Next Year0.59%
Revenue Next 2Y0.65%
Revenue Next 3Y2.54%
Revenue Next 5Y1.05%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MDV Yearly Revenue VS EstimatesMDV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M 40M 50M
MDV Yearly EPS VS EstimatesMDV Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

3

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 95.50 indicates a quite expensive valuation of MDV.
  • Compared to the rest of the industry, the Price/Earnings ratio of MDV is on the same level as its industry peers.
  • MDV's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.98.
  • A Price/Forward Earnings ratio of 110.70 indicates a quite expensive valuation of MDV.
  • MDV's Price/Forward Earnings is on the same level as the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 28.01. MDV is valued rather expensively when compared to this.
Industry RankSector Rank
PE 95.5
Fwd PE 110.7
MDV Price Earnings VS Forward Price EarningsMDV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • MDV's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MDV is cheaper than 76.23% of the companies in the same industry.
  • MDV's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MDV is cheaper than 87.70% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.08
EV/EBITDA 11.79
MDV Per share dataMDV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • MDV's earnings are expected to grow with 22.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-25.69%
EPS Next 3Y22.95%

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 7.32%, MDV is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 6.88, MDV pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.81, MDV pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.32%

5.2 History

  • MDV has been paying a dividend for over 5 years, so it has already some track record.
  • The dividend of MDV decreased in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
MDV Yearly Dividends per shareMDV Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • The earnings of MDV are negative and hence is the payout ratio. MDV will probably not be able to sustain this dividend level.
DP-551.99%
EPS Next 2Y-25.69%
EPS Next 3Y22.95%
MDV Yearly Income VS Free CF VS DividendMDV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

MODIV INDUSTRIAL INC

NYSE:MDV (2/25/2026, 2:27:49 PM)

15.28

-0.06 (-0.39%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-14
Earnings (Next)03-10
Inst Owners23.02%
Inst Owner Change3.13%
Ins Owners3.04%
Ins Owner Change1.47%
Market Cap156.93M
Revenue(TTM)47.04M
Net Income(TTM)-2.68M
Analysts82.22
Price Target18.05 (18.13%)
Short Float %3.05%
Short Ratio8.12
Dividend
Industry RankSector Rank
Dividend Yield 7.32%
Yearly Dividend1.6
Dividend Growth(5Y)N/A
DP-551.99%
Div Incr Years0
Div Non Decr Years2
Ex-Date03-31
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)65.02%
Min EPS beat(2)-100%
Max EPS beat(2)230.03%
EPS beat(4)3
Avg EPS beat(4)104.41%
Min EPS beat(4)-100%
Max EPS beat(4)230.03%
EPS beat(8)5
Avg EPS beat(8)-93.26%
EPS beat(12)7
Avg EPS beat(12)26.74%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.46%
Min Revenue beat(2)-1.65%
Max Revenue beat(2)-1.28%
Revenue beat(4)1
Avg Revenue beat(4)-0.4%
Min Revenue beat(4)-1.65%
Max Revenue beat(4)1.93%
Revenue beat(8)2
Avg Revenue beat(8)-1.17%
Revenue beat(12)5
Avg Revenue beat(12)3.64%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.66%
PT rev (3m)-0.28%
EPS NQ rev (1m)37.64%
EPS NQ rev (3m)0%
EPS NY rev (1m)3.51%
EPS NY rev (3m)-92.98%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.5%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.51%
Valuation
Industry RankSector Rank
PE 95.5
Fwd PE 110.7
P/S 3.34
P/FCF 10.08
P/OCF 9.73
P/B 0.95
P/tB 0.96
EV/EBITDA 11.79
EPS(TTM)0.16
EY1.05%
EPS(NY)0.14
Fwd EY0.9%
FCF(TTM)1.52
FCFY9.92%
OCF(TTM)1.57
OCFY10.28%
SpS4.58
BVpS16.05
TBVpS15.93
PEG (NY)N/A
PEG (5Y)N/A
Graham Number7.6
Profitability
Industry RankSector Rank
ROA -0.54%
ROE -1.63%
ROCE 4.06%
ROIC 3.21%
ROICexc 3.27%
ROICexgc 3.28%
OM 42.5%
PM (TTM) N/A
GM 92.56%
FCFM 33.08%
ROA(3y)-1.01%
ROA(5y)-3.09%
ROE(3y)-3.42%
ROE(5y)-9.27%
ROIC(3y)2.12%
ROIC(5y)1.53%
ROICexc(3y)2.16%
ROICexc(5y)1.58%
ROICexgc(3y)2.18%
ROICexgc(5y)1.6%
ROCE(3y)2.69%
ROCE(5y)1.95%
ROICexgc growth 3Y59.93%
ROICexgc growth 5Y30.52%
ROICexc growth 3Y62.55%
ROICexc growth 5Y34.05%
OM growth 3Y67.86%
OM growth 5Y18.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.08%
GM growth 5Y2.86%
F-Score4
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 1.7
Debt/FCF 17.98
Debt/EBITDA 7.69
Cap/Depr 3.44%
Cap/Sales 1.2%
Interest Coverage 1.51
Cash Conversion 44.32%
Profit Quality N/A
Current Ratio 4.25
Quick Ratio 4.25
Altman-Z 0.11
F-Score4
WACC6.37%
ROIC/WACC0.5
Cap/Depr(3y)581.06%
Cap/Depr(5y)371.93%
Cap/Sales(3y)189.95%
Cap/Sales(5y)123.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)157.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y-174.07%
EPS Next 2Y-25.69%
EPS Next 3Y22.95%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.59%
Revenue growth 3Y7.26%
Revenue growth 5Y13.76%
Sales Q2Q%0.27%
Revenue Next Year0.59%
Revenue Next 2Y0.65%
Revenue Next 3Y2.54%
Revenue Next 5Y1.05%
EBIT growth 1Y11.55%
EBIT growth 3Y80.05%
EBIT growth 5Y35.21%
EBIT Next Year79.8%
EBIT Next 3Y25.75%
EBIT Next 5Y15.97%
FCF growth 1Y114.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.97%
OCF growth 3Y23.3%
OCF growth 5Y30.88%

MODIV INDUSTRIAL INC / MDV FAQ

Can you provide the ChartMill fundamental rating for MODIV INDUSTRIAL INC?

ChartMill assigns a fundamental rating of 4 / 10 to MDV.


What is the valuation status of MODIV INDUSTRIAL INC (MDV) stock?

ChartMill assigns a valuation rating of 3 / 10 to MODIV INDUSTRIAL INC (MDV). This can be considered as Overvalued.


What is the profitability of MDV stock?

MODIV INDUSTRIAL INC (MDV) has a profitability rating of 5 / 10.


What is the valuation of MODIV INDUSTRIAL INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for MODIV INDUSTRIAL INC (MDV) is 95.5 and the Price/Book (PB) ratio is 0.95.


What is the financial health of MODIV INDUSTRIAL INC (MDV) stock?

The financial health rating of MODIV INDUSTRIAL INC (MDV) is 5 / 10.